1. Medtech Insight

J&J Taps Aspect Biosystem's 3D Printing Tech For Meniscus Implant

 
• By Reed Miller

3D bioprinting and tissue engineering specialist Aspect Biosystems has entered a research collaboration with Johnson & Johnson's DePuy Synthes to create bioprinted knee meniscus tissue suitable for surgical therapy. It is one of more than 50 commercial and academic partnerships J&J has entered to develop complementary technologies and materials for its medical devices.

Johnson & Johnson's orthopedics business DePuy Synthes will use Aspect Biosystems Ltd.'s Lab-on-a-Printer 3D bioprinting platform to develop a bioprinted tissue device for surgical knee meniscus replacement.

Aspect CEO Tamer Mohamed told Medtech Insight that Lab-on-a-Printer is highly differentiated from other 3D-printing technologies because it offers the unique capability of creating complex multi-cellular 3D tissues at "industrially relevant throughput

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area